Biotechnology News

October 6, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces Proposed Public Debt Offering

October 6, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces Tender Offers for Eight Series of Notes

October 6, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (publ)(STO:VITR) hereby invites analysts, investors, shareholders and journalists to a Capital Markets Day on November 6. We will talk about Vitrolife’s business, which assists in...

October 6, 2014

LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma, a global healthcare company focused on dermatology, today announced that it has initiated a Phase II clinical trial of a novel muscle relaxant in the United States.

October 4, 2014

NEW YORK--(BUSINESS WIRE)--Marathon Pharmaceuticals today announced positive results from 2 separate - IPRIVASK® studies presented at the International Congress for Joint Reconstruction (ICJR) Transatlantic Meeting

October 3, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, October 30, 2014, after market close, the Company will...

October 3, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--MichBio, the association for Michigan’s biosciences industry, welcomed over 350 bioscience professionals, service providers, and students to its 10th Annual Expo & Conference on September 30 and October 1 in...

October 3, 2014

--(BUSINESS WIRE)--NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Alzheimer’s and Parkinson’s...

October 3, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced that it will highlight the transformative attributes of the company’s PRINT® (Particle Replication In Non-Wetting Templates) technology at the 12th International...

October 3, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO will be in attendance at Outsourcing in Clinical Trials New England on October 7-8 at the Westin Boston Waterfront Hotel and will be represented by its operational management in North America.

October 3, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI reports updated enrollment numbers for its Phase III head and neck cancer clinical trial for September 2014.

October 3, 2014

BALTIMORE--(BUSINESS WIRE)--Cerecor Inc. will present a corporate overview at the 13th Annual BIO Investor Forum in San Francisco, CA.

October 3, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), and its subsidiary OncoCyte Corporation today announced that OncoCyte’s collaborators at The Wistar Institute have completed enrollment of a large, multi-site study evaluating a...

October 3, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness.

October 3, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sevion Therapeutics (OTCQB:SVON), a clinical stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today that, on...

October 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--DecImmune Therapeutics today announced that it has been awarded a $3 million, three-year Phase II SBIR grant to support late preclinical studies and initial clinical trials of DeciMab™, its novel monoclonal...

October 3, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that ten abstracts have been accepted for presentation at IDWeek 2014™, which is taking place in Philadelphia, PA, October 8-12, 2014. The breadth of data...

October 3, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (Nasdaq: OPHT) announced that Todd N. Smith has joined the Company today as Senior Vice President and Chief Commercial Officer, a new position at the Company.

October 3, 2014

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Reports on Results of AGM Voting

October 3, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Bactiguard (STO:BACTI) Bactiguard establishes market presence in Portugal by entering an exclusive distribution agreement with Socime Medical Ltd, covering all products in the Bactiguard infection...

October 3, 2014

TOKYO--(BUSINESS WIRE)--PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”) (Tokyo:4587), announced today that one of the discovery programs initiated under the strategic alliance with Swiss-based Novartis has advanced...

October 3, 2014

GÖTEBORG, Sweden & RADNOR, Penn.--(BUSINESS WIRE)--Regulatory News: Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and endocrinology disorders,...

October 3, 2014

BOSTON--(BUSINESS WIRE)--Allied-Bristol Life Sciences announced that Satish Jindal, Ph.D., formerly Vice President of R&D at Bristol-Myers, will lead efforts to develop biopharmaceutical innovations from top US universities.

October 2, 2014

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., (FibroGen) a biotechnology company focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs...

October 2, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, today announced CEO Robert G. Finizio will present an overview of the company at the 13th annual BIO Investor Forum, Wednesday,...

October 2, 2014

ST. LOUIS--(BUSINESS WIRE)--APT Therapeutics, Inc. is developing an investigational new drug, APT102, for heart attack and stroke patients. According to a recent study published in Science Translational Medicine, APT102 maintained optimal blood...

October 2, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it will host a Key Opinion Leader Breakfast on Tuesday, October 14, 2014 from 8:00-9:30 a.m. Eastern time in New...

October 2, 2014

CHEVY CHASE, Md.--(BUSINESS WIRE)--Nozin antiseptic drug found effective against Staph aureus nasal carriage. Health experts see published study on non-antibiotic Nozin Nasal Sanitizer antiseptic as significant for infection control.

October 2, 2014

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. receives a milestone payment from Bristol-Myers Squibb, which has nominated an NMDA receptor compound as a drug development candidate for treatment-resistant depression.

October 2, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics today announced that it will hold an Analyst and Investor Event in New York City, New York on Thursday, October 9, 2014.

October 2, 2014

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--Record number of licensing opportunities presented at BioPharm America™ 2014 International Life Science Partnering Event in Boston.

October 2, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services with over 100 beds, continues its collaboration with Cambridge Cognition on electronic Visual Analog...

October 2, 2014

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises Appoints Drew Milburn as CEO of its U.S. Subsidiary. Drew has 10+ years experience in the marijuana sector & has advised businesses, government and enforcement agencies in CAN & US

October 2, 2014

VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix appoints Ms. Susan Woodward as CFO and retains Mr. Wallace Boyack, lawyer.

October 2, 2014

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced the Company will be participating at the Surfaces in Biomaterials Foundation’s 24th Annual BioInterface Conference 2014,...

October 2, 2014

WASHINGTON--(BUSINESS WIRE)--BIO President and CEO James C. Greenwood congratulates India’s new Prime Minister, Narendra Modi on his successful first official visit to the United States.

October 2, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth to Sponsor Turning the Tide Against Cancer 2014 National Conference

October 2, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm introduces a Single-Cell Whole Exome Sequencing workflow for its C1 Single-Cell Auto Prep System.

October 2, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions today announced that it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag™ Antibody-Drug Conjugate (ADC) technology platform.

October 2, 2014

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Three months ago Manhattan Scientifics (OTCQB: MHTX) announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston. The Company's technology uses iron...

October 2, 2014

MIDLAND, Mich.--(BUSINESS WIRE)--The Dow Chemical Company (NYSE: DOW) today announced several updates regarding divestiture and portfolio management actions – demonstrating the Company’s commitment to previously established targets and its...

October 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its investigational cancer medicine, AP26113, has received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the...

October 2, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has earned a $60 million milestone payment from Novartis related to reimbursement of Jakavi® (ruxolitinib) in Europe. Incyte will record this amount as...

October 2, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SAFEBRIDGE® CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, announced that SABRE Health & Safety, LLC ("SABRE") in Easton, Pennsylvania has joined SafeBridge as of...